This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
OTC Markets Group Inc. (OTCM) Misses Q1 Earnings Estimates
by Zacks Equity Research
OTC Markets Group Inc. (OTCM) delivered earnings and revenue surprises of -4.62% and 5.97%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Coinbase Global, Inc. (COIN) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Coinbase Global, Inc. (COIN) delivered earnings and revenue surprises of -665.71% and 20.59%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
MarketAxess (MKTX) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
MarketAxess (MKTX) delivered earnings and revenue surprises of 1.76% and 0.08%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Hold is an Apt Strategy for Nasdaq (NDAQ) Now
by Zacks Equity Research
Nasdaq's (NDAQ) focus on repositioning its business and aims to generate revenues from high growth Market Technology and Investment Intelligence segments bodes well.
Here's Why You Should Hold On to Cboe Global (CBOE) Stock
by Zacks Equity Research
Cboe Global (CBOE) is set to grow on organic growth in access and capacity fees and proprietary market data fees and solid capital position.
OTC Markets Group Inc. (OTCM) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
OTC Markets Group Inc. (OTCM) delivered earnings and revenue surprises of 34.55% and 11.15%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Should You Hold Cboe Global (CBOE) Stock in Your Portfolio?
by Zacks Equity Research
Cboe Global (CBOE) is set to grow on higher trading volumes, strategic acquisitions and solid capital position.
Here's Why Investing in Intercontinental (ICE) is Prudent Now
by Zacks Equity Research
Intercontinental Exchange (ICE) is poised to grow, attributable to higher interest rate business, growth across financial futures and options complex, and adoption of digital workflow tools.
CME Group (CME) December ADV Up Y/Y, Q4 & 2021 ADV Robust
by Zacks Equity Research
CME Group (CME) reported record volumes for the fourth quarter as well as full-year 2021.
Nasdaq (NDAQ) Rallies 60% YTD: More Room for Upside Left?
by Zacks Equity Research
Accelerating organic growth, focus on ramping up on-trading revenue base, strategic buyouts to capitalize on growing markets opportunities, effective capital deployment and upbeat guidance continue to drive Nasdaq (NDAQ).
CME Group (CME) Rallies 24% YTD: More Room for Upside Left?
by Zacks Equity Research
Compelling derivative product lines, global presence, a growing proportion of volume from customers outside the United States, focus on over-the-counter clearing services and effective capital deployment continue to drive CME Group (CME).
Zacks Industry Outlook Highlights: Cboe Global Markets, CME Group, Intercontinental Exchange, Nasdaq and OTC Markets Group
by Zacks Equity Research
Zacks Industry Outlook Highlights: Cboe Global Markets, CME Group, Intercontinental Exchange, Nasdaq and OTC Markets Group
5 Securities and Exchanges Industry Stocks to Benefit From Increased Trading
by Tanuka De
Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like CBOE, CME, ICE, NDAQ and OTCM. However, compliance with regulations remains a challenge.
CME Group (CME) Schedules Launch of Portside Iron Ore Futures
by Zacks Equity Research
CME Group (CME) is set to launch Iron Ore Futures on Jan 10 to add to the existing ferrous suite of products.
MarketAxess' (MKTX) Platform to be Utilized by Flow Traders
by Zacks Equity Research
MarketAxess' (MKTX) trading platform to be used by Flow Traders wherein the latter will act as an active liquidity provider.
CME Group (CME) Boosts Crypto Trading With Micro Ether Futures
by Zacks Equity Research
CME Group (CME) enhances the crypto derivatives offering with the launch of Micro Ether Futures.
Nasdaq (NDAQ) November Volumes Increase Year Over Year
by Zacks Equity Research
Nasdaq (NDAQ) November 2021 volume reflects increase in U.S. equity options volume as well as higher European equity volume and European fixed income volume.
CME Group (CME) November ADV Increases at Four Product Lines
by Zacks Equity Research
CME Group's (CME) average daily volume of 23.1 million contracts per day increases 20% year over year due to higher volumes in four of the six product lines.
Why It's Worth Betting on Intercontinental (ICE) Stock Now
by Zacks Equity Research
Expansive product and service portfolio and solid balance sheet poise Intercontinental Exchange (ICE) well for growth.
Cboe Global (CBOE) Stock Gains 41% YTD: More Room for Growth?
by Zacks Equity Research
Increased medium-term target, strong market position, global reach, strength in its proprietary products, and solid capital position continue to drive Cboe Global (CBOE).
Cboe Global (CBOE) Raises Medium-Term Financial Target
by Zacks Equity Research
Cboe Global (CBOE) expects to deliver total net revenue growth of 5-7% annually, an increase from 4-6% growth expected earlier.
Cboe Global (CBOE) to Expand in Canada With Aequitas Buyout
by Zacks Equity Research
Cboe Global's (CBOE) pending buyout of Aequitas Innovations also known as NEO is likely to broaden its North American equities business.
OTC Markets Group Inc. (OTCM) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
OTC Markets Group Inc. (OTCM) delivered earnings and revenue surprises of 34.78% and 13.96%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
OTC Markets Group Inc. (OTCM) Earnings Expected to Grow: What to Know Ahead of Q3 Release
by Zacks Equity Research
OTC Markets Group Inc. (OTCM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CME Group (CME) Futures Products Aid Amid Cost Concerns
by Zacks Equity Research
CME Group (CME) holds potential to reap benefits driven by expansion of futures products, strong global presence, prudent capital deployment and sufficient liquidity position.